Walgreens enters clinical trials business through new unit


A individual is viewed procuring in Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York Metropolis, U.S., November 26, 2021. REUTERS/Andrew Kelly

Sign up now for Cost-free unrestricted entry to Reuters.com

June 16 (Reuters) – Walgreens Boots Alliance Inc (WBA.O) on Thursday launched a clinical trials small business that aims to use client details from its pharmacies to assist push up recruitment in experiments performed by drugmakers.

Greatest acknowledged for its chain of drugstores, Walgreens has been searching to expand further than its core small business and put in $5.5 billion last yr to choose bulk stakes in two health and fitness care vendors, VillageMD and CareCentrix.

With the scientific trials business, the enterprise ideas to use its extensive trove of knowledge and new solutions to aid lower prices for drugmakers and seize a share of the about $83 billion sector.

“This is nonetheless another way we are building our next advancement engine of buyer-centric healthcare alternatives,” claimed Ramita Tandon, Walgreen’s chief scientific trials officer.

Sign up now for Absolutely free limitless access to Reuters.com

Reporting by Manas Mishra in Bengaluru Editing by Aditya Soni

Our Requirements: The Thomson Reuters Have faith in Concepts.


Supply backlink